PRKN and cancer: Interestingly, YQ456 disrupted mitochondrial autophagy to induce cancer cell death by inhibiting Rab7‐meditated lysosomal degradation, as evidenced by the decline of PINK1/Parkin pathway, decreased LC3‐II/LC3‐I ratio, and elevated P62 expression (Figure 8F).